TLRY : Tilray Inc Stock Profile

Last Updated: 3/12/2024 0:47:16

Tilray Inc trades with the ticker TLRY on the TSX and is in the Drug Manufacturers – Specialty & Generic industry.

Overview
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
 

Looking to invest in Tilray Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.

TLRY.TO Stock Price and Key Stats

ETF Key Stats

Exchange: TSX

Market Cap : $1736.755MM

PE Ratio:

Price: 1.67 (Updated: 3/12/2024 0:47:16)



Tilray Inc (TLRY) vs Competitors in Drug Manufacturers – Specialty & Generic

Lets see how TLRY.TO stacks up against others in the Drug Manufacturers – Specialty & Generic asset management industry. We have identified its main peers as:

Aurora Cannabis Inc, Avicanna Inc, Bausch Health Companies Inc, Cardiol Therapeutics Inc, Cronos Group Inc

.

Drug Manufacturers – Specialty & Generic Industry Comparisons

Company Market Cap ($MM) P/E Ratio EV/EBITDA Dividend Yield
Aurora Cannabis Inc (ACB) $222.521 N/A -0.115 N/A%
Avicanna Inc (AVCN) $43.759 N/A -4.217 N/A%
Bausch Health Companies Inc (BHC) $4,553.034 N/A 15.169 N/A%
Cardiol Therapeutics Inc (CRDL) $132.181 N/A -3.0 N/A%
Cronos Group Inc (CRON) $1,018.068 N/A 1.918 N/A%

EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield  

Comparisons within Drug Manufacturers – Specialty & Generic

  • Tilray Inc (TLRY) vs Aurora Cannabis Inc (ACB)
    • TLRY has higher EPS (-3.07 vs -79.2). ACB and TLRY both have P/E’s under 0.
  • Tilray Inc (TLRY) vs Avicanna Inc (AVCN)
    • AVCN has higher EPS (-0.17 vs -3.07). AVCN and TLRY both have P/E’s under 0.
  • Tilray Inc (TLRY) vs Bausch Health Companies Inc (BHC)
    • BHC has higher EPS (-2.18 vs -3.07). BHC and TLRY both have P/E’s under 0.
  • Tilray Inc (TLRY) vs Cardiol Therapeutics Inc (CRDL)
    • CRDL has higher EPS (-0.43 vs -3.07). CRDL and TLRY both have P/E’s under 0.
  • Tilray Inc (TLRY) vs Cronos Group Inc (CRON)
    • CRON has higher EPS (-0.24 vs -3.07). CRON and TLRY both have P/E’s under 0.

Our Recommendation: Hold
Features a lower EV/EBITDA ratio (-1.69) than the industry average (0.33), indicating attractive valuation.
 

How to Buy TLRY stock on the TSX

You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:

ImageProduct TitleFeaturesPrice
Editor's Choice
Wealthsimple Trade

Wealthsimple Trade

  • ETF buys and sells have $0 trading fees
  • Desktop and mobile trading
  • Reputable Brand
  • Beautiful Design
Get $25 Signup Bonus
Reliable Pick
Questrade

Questrade

  • ETF buys have $0 trading fees
  • Desktop and mobile trading
  • Most types of accounts available
Get $50 Free Stock Trades
 
Photo of author
Author Bio - Qayyum Rajan is a CFA Charterholder with 10+ years of finance experience and the co-creator of Wealthawesome.com. He has previously worked as a portfolio manager at RBC Dominion Securities and other roles at asset managers like Sentry Investments. He then started building websites and fintech apps to bring finance to everyone.

Check Out These Posts:

Leave a Comment